XML 25 R46.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Significant Accounting Policies (Details 4) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Revenue Recognition [Abstract]    
Shelf life of Remodulin, Tyvaso and Orenitram sold to customers, minimum 1 year  
Inventory holding period of Remodulin,Tyvaso and Orenitram, low end of range 30 days  
Inventory holding period of Remodulin, Tyvaso and Orenitram, high end of range 60 days  
Maximum exchanges of Remodulin, Tyvaso and Orenitram as compared to the total volume of units sold (as a percent) 1.00%uthr_PercentageOfRemodulinExchangesToTotalVolumeOfVialsSoldMaximum  
Reduction in allowance for returns associated with goods due to change in the methodology for estimating returns   $ 3.1uthr_DecreaseInAllowanceForReturnsForGoodsDueToRevisionInMethodologyForEstimatingReturns
Income taxes    
Minimum percentage of likelihood of realization of recognized tax benefit 50.00%uthr_PercentageOfLikelihoodOfRealizationOfRecognizedTaxBenefitMinimum